Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity

Gry I. Skodje, Vikas K. Sarna, Ingunn H. Minelle, +6

Gastroenterology

Food IntoleranceAllergyClinical PresentationInduces SymptomsCeliac Disease +1

Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease

Louise F. Risnes, Asbjørn Christophersen, Shiva Dahal‐Koirala, +6

Journal of Clinical Investigation

Autoimmune DiseaseCeliac DiseaseT CellsT-regulatory CellPathogenesis +12

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease

Gautam Goel, Jason A. Tye–Din, Shuo‐Wang Qiao, +13

Science Advances

Mosaic deletion patterns of the human antibody heavy chain gene locus shown by Bayesian haplotyping

Moriah Gidoni, Omri Snir, Ayelet Peres, +10

Nature Communications

HLA-DQ–Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption

Vikas K. Sarna, Knut E. A. Lundin, Lars Mørkrid, +3

Gastroenterology

NutritionGluten ConsumptionFood IntoleranceAutoimmune DiseaseAllergy +5

HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge

Vikas K. Sarna, Gry I. Skodje, Henrik M. Reims, +4

Gut

TCR sequencing of single cells reactive to DQ2.5-glia-α2 and DQ2.5-glia-ω2 reveals clonal expansion and epitope-specific V-gene usage

Shiva Dahal‐Koirala, Louise F. Risnes, Asbjørn Christophersen, +4

Mucosal Immunology

ImmunogeneticsSingle Cell SequencingImmune Cell DevelopmentTcr SequencingImmune Regulation +9

Cytokine release after gluten ingestion differentiates coeliac disease from self‐reported gluten sensitivity

Jason A. Tye–Din, Gry I. Skodje, Vikas K. Sarna, +9

United European Gastroenterology Journal

In Well‐Treated Celiac Patients Low‐Level Mucosal Inflammation Predicts Response to 14‐day Gluten Challenge

Daniel Stray, Maria Stensland, Vikas K. Sarna, +3

Advanced Science

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial

Anna‐Maria Hoffmann‐Vold, Håvard Fretheim, Vikas K. Sarna, +13

BMJ Open